Anti-IgE class drugs

1 result
Genentech, Inc.
Usage: XOLAIR is indicated for adults and children 6 years and older with moderate to severe persistent asthma, chronic rhinosinusitis with nasal polyps (adults 18+), IgE-mediated food allergies (ages 1+), and chronic spontaneous urticaria (ages 12+). It is not for acute bronchospasm or emergency allergic reactions.